EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study

Stefan Macher iD, Gabriel Bsteh iD, Romana Höftberger iD, Thomas Berger, Paulus Rommer, Tobias Zrzavy iD

Annals of Clinical and Translational Neurology · 2023-10 · 10 (10) · 1768-1775

DOI: 10.1002/acn3.51865 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 06.08.2023. Verfasst von Stefan Macher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Hashimoto Disease, Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Assessing severity of antibody‐mediated encephalitis (AE) or paraneoplastic encephalitis (PE) requires valid and reliable scores to guide treatment decisions and predict outcome both in clinical routine and studies. We aimed to validate the prognostic value of the clinical assessment scale in autoimmune encephalitis (CASE) and the anti‐NMDAR‐encephalitis one‐year functional status (NEOS) score in patients suffering from AE and PE in a large monocentric cohort.

Methods

We retrospectively applied the CASE and NEOS score to patients with definite AE and PE treated at a tertiary hospital. Correlations were established between the CASE and NEOS score and the modified Rankin scale (mRs). Multivariable analyses were calculated to identify predictors of outcome.

Results

Thirty‐four patients (27 AE, 7 PE) were included. Correlations between mRS and CASE score were strongest in patients with AE compared to PE at all intervals, but in the subgroups (LGI1, NMDAR, GAD, miscellaneous surface antibodies, PE) the correlation was strongest in the interval after baseline. Patients with AE seemed to display better outcomes compared to PE, which was underlined by multivariable analysis. Improvement was mostly observed within 6–12 months after disease onset, after which little or no further improvement was noted with some exception for two patients with anti‐NMDARE who recovered substantially even after 12 months of treatment. The NEOS score significantly predicted the outcome at last follow‐up in patients with AE with a sensitivity of 79% at a cut‐off value of 2 points (AUC 0.79, 95% CI 0.58–0.99, p = 0.04).

Interpretation

The CASE and NEOS score are suitable supplementary tools in addition to the mRS for capturing diverse symptoms, for grading and monitoring symptom severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hashimoto DiseaseAnti-N-Methyl-D-Aspartate Receptor EncephalitisRetrospective StudiesCohort StudiesEncephalitisHumans

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Comprehensive Center for Clinical Neurosciences & Mental health, Medical University of Vienna, Vienna, Austria.
  • Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Stefan Macher, Gabriel Bsteh, Romana Höftberger, Tobias Zrzavy

Zitieren

APA

Macher, S., Bsteh, G., Höftberger, R., Berger, T., Rommer, P., & Zrzavy, T. (2023). Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study. Annals of Clinical and Translational Neurology, 10(10), 1768-1775. https://doi.org/10.1002/acn3.51865

Vancouver

Macher S, Bsteh G, Höftberger R, Berger T, Rommer P, Zrzavy T. Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study. Annals of Clinical and Translational Neurology. 2023;10(10):1768-1775. doi:10.1002/acn3.51865

BibTeX
@article{Macher2023,
  author = {Macher, Stefan and Bsteh, Gabriel and Höftberger, Romana and Berger, Thomas and Rommer, Paulus and Zrzavy, Tobias},
  title = {Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2023},
  volume = {10},
  number = {10},
  pages = {1768--1775},
  doi = {10.1002/acn3.51865}
}
Kostenlos starten →